CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis

被引:0
作者
Guo, Yang [1 ]
Zhou, Shan [2 ]
Liu, Feng [4 ]
Zhang, Bin [3 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 2, Dept Endodont, Harbin 150086, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 2, Dept Orthodont, Harbin 150086, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Dept Implantol, Harbin 150086, Heilongjiang, Peoples R China
[4] Harbin Childrens Hosp, Dept Stomatol, Harbin, Heilongjiang, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2015年 / 8卷 / 11期
关键词
CYP2E1; polymorphism; oral cancer; meta-analysis; SQUAMOUS-CELL CARCINOMA; UPPER AERODIGESTIVE TRACT; GENETIC POLYMORPHISMS; NECK-CANCER; METABOLIZING-ENZYMES; OROPHARYNGEAL CANCER; CYTOCHROME P-4502E1; ALCOHOL-CONSUMPTION; RISK; HEAD;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several studies have investigated the associations between CYP2E1 RsaI/PstI polymorphisms and oral cancer risk, but results have been inconclusive. In order to derive a more precise estimation of the relationship, a meta-analysis was performed. PubMed and China National Knowledge Infrastructure (CNKI) searches were carried out for relevant studies published before September 2014. Meta-analysis was performed with the Stata, version 11.0. A total of 14 case control studies, including 1,962 cases and 3,271 controls, were selected. Overall, significant association was found between the CYP2E1 RsaI/PstI polymorphisms and oral cancer risk (for c1c1 vs. c1c2, OR=0.72, 95% CI=0.56-0.91; for c1c1 vs. c2c2, OR=0.45, 95% CI=0.25-0.82), while not for the dominant model (c1c1 vs. c1c2+ c2c2, OR=0.84, 95% CI=0.69-1.01). In the subgroup analysis by ethnicity, statistically significant association was found in Caucasian, East Asian and South Asian. This meta-analysis suggests that the CYP2E1 RsaI/PstI polymorphisms are a risk factor for developing oral cancer.
引用
收藏
页码:14685 / 14692
页数:8
相关论文
共 36 条
[1]   Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk [J].
Anantharaman, Devasena ;
Samant, Tanuja A. ;
Sen, Subrata ;
Mahimkar, Manoj B. .
ORAL ONCOLOGY, 2011, 47 (09) :866-872
[2]  
Balaji L, 2011, ASIAN PAC J CANCER P, V12, P1523
[3]  
Bouchardy C, 2000, INT J CANCER, V87, P734, DOI 10.1002/1097-0215(20000901)87:5<734::AID-IJC17>3.0.CO
[4]  
2-E
[5]   Genetic Polymorphisms of ADH1C and CYP2E1 and Risk of Oral Squamous Cell Carcinoma [J].
Brocic, Miroslav ;
Supic, Gordana ;
Zeljic, Katarina ;
Jovic, Nebojsa ;
Kozomara, Ruzica ;
Zagorac, Sladjana ;
Zlatkovic, Milica ;
Magic, Zvonko .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2011, 145 (04) :586-593
[6]   Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes [J].
Buch, Shama C. ;
Nazar-Stewart, Valle ;
Weissfeld, Joel L. ;
Romkes, Marjorie .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (09) :1139-1147
[7]   HUMAN-CHROMOSOME ANALYSIS IN 24 CASES OF PRIMARY-CARCINOMA OF THE LARGE-INTESTINE - CONTRIBUTION OF THE G-BANDING TECHNIQUE [J].
COUTURIERTURPIN, MH ;
COUTURIER, D ;
NEPVEUX, P ;
LOUVEL, A ;
CHAPUIS, Y ;
GUERRE, J .
BRITISH JOURNAL OF CANCER, 1982, 46 (06) :856-869
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[10]   Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer [J].
Figaro Gattas, Gilka Jorge ;
Brasilino de Carvalho, Marcos ;
Salete Siraque, Maria ;
Curioni, Otavio A. ;
Kohler, Priscila ;
Eluf-Neto, Jose ;
Wunsch-Filho, Victor .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (09) :819-826